nodes	percent_of_prediction	percent_of_DWPC	metapath
Tazarotene—CYP2C8—Fenofibrate—coronary artery disease	0.112	0.183	CbGbCtD
Tazarotene—CYP2C8—Gemfibrozil—coronary artery disease	0.0895	0.146	CbGbCtD
Tazarotene—CYP2C8—Clopidogrel—coronary artery disease	0.0776	0.127	CbGbCtD
Tazarotene—CYP2C8—Pitavastatin—coronary artery disease	0.0678	0.111	CbGbCtD
Tazarotene—CYP2C8—Acetylsalicylic acid—coronary artery disease	0.0487	0.0796	CbGbCtD
Tazarotene—CYP2C8—Simvastatin—coronary artery disease	0.0465	0.0759	CbGbCtD
Tazarotene—CYP2C8—Pravastatin—coronary artery disease	0.0455	0.0743	CbGbCtD
Tazarotene—CYP2C8—Lovastatin—coronary artery disease	0.0455	0.0743	CbGbCtD
Tazarotene—CYP2C8—Atorvastatin—coronary artery disease	0.0414	0.0677	CbGbCtD
Tazarotene—CYP2C8—Losartan—coronary artery disease	0.0379	0.0619	CbGbCtD
Tazarotene—Localized exfoliation—Losartan—coronary artery disease	0.00416	0.024	CcSEcCtD
Tazarotene—Instillation site pain—Furosemide—coronary artery disease	0.00357	0.0205	CcSEcCtD
Tazarotene—Swelling—Tirofiban—coronary artery disease	0.00287	0.0165	CcSEcCtD
Tazarotene—Application site pain—Furosemide—coronary artery disease	0.00264	0.0152	CcSEcCtD
Tazarotene—Hypertriglyceridaemia—Eplerenone—coronary artery disease	0.00262	0.0151	CcSEcCtD
Tazarotene—Hypertriglyceridaemia—Olmesartan—coronary artery disease	0.0024	0.0138	CcSEcCtD
Tazarotene—Blood triglycerides increased—Eplerenone—coronary artery disease	0.0023	0.0132	CcSEcCtD
Tazarotene—Skin hyperpigmentation—Niacin—coronary artery disease	0.00227	0.013	CcSEcCtD
Tazarotene—Blister—Fenofibrate—coronary artery disease	0.00223	0.0128	CcSEcCtD
Tazarotene—Skin irritation—Timolol—coronary artery disease	0.00217	0.0125	CcSEcCtD
Tazarotene—Blood triglycerides increased—Olmesartan—coronary artery disease	0.00211	0.0121	CcSEcCtD
Tazarotene—Burning sensation—Niacin—coronary artery disease	0.00194	0.0112	CcSEcCtD
Tazarotene—Acne—Fenofibrate—coronary artery disease	0.00191	0.011	CcSEcCtD
Tazarotene—Blood triglycerides increased—Furosemide—coronary artery disease	0.00177	0.0102	CcSEcCtD
Tazarotene—Haemoglobin—Tirofiban—coronary artery disease	0.00176	0.0101	CcSEcCtD
Tazarotene—Haemorrhage—Tirofiban—coronary artery disease	0.00175	0.0101	CcSEcCtD
Tazarotene—Blister—Captopril—coronary artery disease	0.00171	0.00984	CcSEcCtD
Tazarotene—Eczema—Gemfibrozil—coronary artery disease	0.0017	0.0098	CcSEcCtD
Tazarotene—Blister—Furosemide—coronary artery disease	0.00161	0.00928	CcSEcCtD
Tazarotene—Dermatitis contact—Fenofibrate—coronary artery disease	0.00159	0.00915	CcSEcCtD
Tazarotene—Inflammation—Ezetimibe—coronary artery disease	0.00159	0.00914	CcSEcCtD
Tazarotene—Inflammation—Simvastatin—coronary artery disease	0.00151	0.00871	CcSEcCtD
Tazarotene—Skin discolouration—Niacin—coronary artery disease	0.00149	0.00859	CcSEcCtD
Tazarotene—Stinging—Losartan—coronary artery disease	0.00138	0.00797	CcSEcCtD
Tazarotene—Burning sensation—Ramipril—coronary artery disease	0.00138	0.00797	CcSEcCtD
Tazarotene—Dermatitis contact—Niacin—coronary artery disease	0.00133	0.00767	CcSEcCtD
Tazarotene—Eczema—Fenofibrate—coronary artery disease	0.0013	0.00748	CcSEcCtD
Tazarotene—Skin exfoliation—Niacin—coronary artery disease	0.00129	0.00741	CcSEcCtD
Tazarotene—Eczema—Clopidogrel—coronary artery disease	0.00128	0.00735	CcSEcCtD
Tazarotene—Oedema—Tirofiban—coronary artery disease	0.00124	0.00715	CcSEcCtD
Tazarotene—Dermatitis bullous—Fenofibrate—coronary artery disease	0.00122	0.00703	CcSEcCtD
Tazarotene—Swelling—Simvastatin—coronary artery disease	0.00121	0.00696	CcSEcCtD
Tazarotene—Photosensitivity reaction—Gemfibrozil—coronary artery disease	0.00121	0.00694	CcSEcCtD
Tazarotene—Dermatitis bullous—Clopidogrel—coronary artery disease	0.0012	0.00691	CcSEcCtD
Tazarotene—Eczema—Simvastatin—coronary artery disease	0.00119	0.00683	CcSEcCtD
Tazarotene—Stinging—Timolol—coronary artery disease	0.00116	0.00668	CcSEcCtD
Tazarotene—Swelling—Valsartan—coronary artery disease	0.00114	0.00657	CcSEcCtD
Tazarotene—Eczema—Olmesartan—coronary artery disease	0.00111	0.00642	CcSEcCtD
Tazarotene—Discomfort—Pitavastatin—coronary artery disease	0.00109	0.00629	CcSEcCtD
Tazarotene—Eczema—Niacin—coronary artery disease	0.00109	0.00627	CcSEcCtD
Tazarotene—Skin exfoliation—Losartan—coronary artery disease	0.00107	0.00616	CcSEcCtD
Tazarotene—Pain—Tirofiban—coronary artery disease	0.00106	0.00612	CcSEcCtD
Tazarotene—Swelling—Enalapril—coronary artery disease	0.00106	0.00608	CcSEcCtD
Tazarotene—Dermatitis bullous—Valsartan—coronary artery disease	0.00105	0.00606	CcSEcCtD
Tazarotene—Eczema—Trandolapril—coronary artery disease	0.00104	0.00599	CcSEcCtD
Tazarotene—Haemoglobin—Ticagrelor—coronary artery disease	0.00104	0.00598	CcSEcCtD
Tazarotene—Haemorrhage—Ticagrelor—coronary artery disease	0.00103	0.00595	CcSEcCtD
Tazarotene—Dermatitis bullous—Niacin—coronary artery disease	0.00102	0.00589	CcSEcCtD
Tazarotene—Eczema—Telmisartan—coronary artery disease	0.00102	0.00589	CcSEcCtD
Tazarotene—Oedema peripheral—Ticagrelor—coronary artery disease	0.00102	0.00586	CcSEcCtD
Tazarotene—Eczema—Perindopril—coronary artery disease	0.000966	0.00556	CcSEcCtD
Tazarotene—Swelling—Furosemide—coronary artery disease	0.000956	0.00551	CcSEcCtD
Tazarotene—Dermatitis bullous—Captopril—coronary artery disease	0.000935	0.00538	CcSEcCtD
Tazarotene—Swelling—Losartan—coronary artery disease	0.000923	0.00531	CcSEcCtD
Tazarotene—Photosensitivity reaction—Fenofibrate—coronary artery disease	0.000921	0.0053	CcSEcCtD
Tazarotene—Haemoglobin—Acetylsalicylic acid—coronary artery disease	0.000908	0.00523	CcSEcCtD
Tazarotene—Haemorrhage—Acetylsalicylic acid—coronary artery disease	0.000904	0.0052	CcSEcCtD
Tazarotene—Photosensitivity reaction—Lovastatin—coronary artery disease	0.000899	0.00518	CcSEcCtD
Tazarotene—Dry skin—Niacin—coronary artery disease	0.000897	0.00516	CcSEcCtD
Tazarotene—Dry skin—Pravastatin—coronary artery disease	0.000883	0.00508	CcSEcCtD
Tazarotene—Dermatitis bullous—Furosemide—coronary artery disease	0.000883	0.00508	CcSEcCtD
Tazarotene—Photosensitivity reaction—Ezetimibe—coronary artery disease	0.000882	0.00508	CcSEcCtD
Tazarotene—Dry skin—Trandolapril—coronary artery disease	0.000858	0.00494	CcSEcCtD
Tazarotene—Dry skin—Enalapril—coronary artery disease	0.000854	0.00492	CcSEcCtD
Tazarotene—Dry skin—Telmisartan—coronary artery disease	0.000843	0.00485	CcSEcCtD
Tazarotene—Photosensitivity reaction—Simvastatin—coronary artery disease	0.000841	0.00484	CcSEcCtD
Tazarotene—Haemoglobin—Clopidogrel—coronary artery disease	0.000798	0.00459	CcSEcCtD
Tazarotene—Dry skin—Perindopril—coronary artery disease	0.000796	0.00458	CcSEcCtD
Tazarotene—Oedema peripheral—Fenofibrate—coronary artery disease	0.000795	0.00458	CcSEcCtD
Tazarotene—Photosensitivity reaction—Valsartan—coronary artery disease	0.000794	0.00457	CcSEcCtD
Tazarotene—Haemorrhage—Clopidogrel—coronary artery disease	0.000794	0.00457	CcSEcCtD
Tazarotene—Photosensitivity reaction—Olmesartan—coronary artery disease	0.00079	0.00455	CcSEcCtD
Tazarotene—Oedema peripheral—Clopidogrel—coronary artery disease	0.000782	0.0045	CcSEcCtD
Tazarotene—Oedema peripheral—Ezetimibe—coronary artery disease	0.000762	0.00438	CcSEcCtD
Tazarotene—Photosensitivity reaction—Pravastatin—coronary artery disease	0.00076	0.00438	CcSEcCtD
Tazarotene—Pain—Penbutolol—coronary artery disease	0.000753	0.00434	CcSEcCtD
Tazarotene—Oedema—Gemfibrozil—coronary artery disease	0.000752	0.00433	CcSEcCtD
Tazarotene—Pruritus—Pitavastatin—coronary artery disease	0.000751	0.00432	CcSEcCtD
Tazarotene—Dry skin—Losartan—coronary artery disease	0.000746	0.0043	CcSEcCtD
Tazarotene—Oedema peripheral—Eplerenone—coronary artery disease	0.000746	0.00429	CcSEcCtD
Tazarotene—Photosensitivity reaction—Trandolapril—coronary artery disease	0.000738	0.00425	CcSEcCtD
Tazarotene—Photosensitivity reaction—Enalapril—coronary artery disease	0.000735	0.00423	CcSEcCtD
Tazarotene—Photosensitivity reaction—Captopril—coronary artery disease	0.000705	0.00406	CcSEcCtD
Tazarotene—Eczema—Lisinopril—coronary artery disease	0.000704	0.00406	CcSEcCtD
Tazarotene—Erythema—Fenofibrate—coronary artery disease	0.000703	0.00405	CcSEcCtD
Tazarotene—Haemoglobin—Valsartan—coronary artery disease	0.0007	0.00403	CcSEcCtD
Tazarotene—Haemorrhage—Valsartan—coronary artery disease	0.000696	0.00401	CcSEcCtD
Tazarotene—Photosensitivity reaction—Perindopril—coronary artery disease	0.000685	0.00394	CcSEcCtD
Tazarotene—Oedema peripheral—Olmesartan—coronary artery disease	0.000683	0.00393	CcSEcCtD
Tazarotene—Haemoglobin—Niacin—coronary artery disease	0.000681	0.00392	CcSEcCtD
Tazarotene—Haemorrhage—Niacin—coronary artery disease	0.000677	0.0039	CcSEcCtD
Tazarotene—Erythema—Ezetimibe—coronary artery disease	0.000673	0.00387	CcSEcCtD
Tazarotene—Rash—Pitavastatin—coronary artery disease	0.000669	0.00385	CcSEcCtD
Tazarotene—Dermatitis—Pitavastatin—coronary artery disease	0.000668	0.00385	CcSEcCtD
Tazarotene—Oedema peripheral—Niacin—coronary artery disease	0.000667	0.00384	CcSEcCtD
Tazarotene—Photosensitivity reaction—Furosemide—coronary artery disease	0.000666	0.00383	CcSEcCtD
Tazarotene—Pain—Gemfibrozil—coronary artery disease	0.000643	0.0037	CcSEcCtD
Tazarotene—Photosensitivity reaction—Losartan—coronary artery disease	0.000642	0.0037	CcSEcCtD
Tazarotene—Erythema—Simvastatin—coronary artery disease	0.000642	0.0037	CcSEcCtD
Tazarotene—Oedema peripheral—Trandolapril—coronary artery disease	0.000638	0.00367	CcSEcCtD
Tazarotene—Oedema peripheral—Telmisartan—coronary artery disease	0.000627	0.00361	CcSEcCtD
Tazarotene—Haemoglobin—Perindopril—coronary artery disease	0.000604	0.00347	CcSEcCtD
Tazarotene—Haemorrhage—Perindopril—coronary artery disease	0.0006	0.00346	CcSEcCtD
Tazarotene—Oedema peripheral—Perindopril—coronary artery disease	0.000592	0.0034	CcSEcCtD
Tazarotene—Discomfort—Fenofibrate—coronary artery disease	0.000591	0.0034	CcSEcCtD
Tazarotene—Erythema—Niacin—coronary artery disease	0.000589	0.00339	CcSEcCtD
Tazarotene—Discomfort—Lovastatin—coronary artery disease	0.000577	0.00332	CcSEcCtD
Tazarotene—Oedema—Fenofibrate—coronary artery disease	0.000574	0.0033	CcSEcCtD
Tazarotene—Discomfort—Ezetimibe—coronary artery disease	0.000566	0.00326	CcSEcCtD
Tazarotene—Pain—Rosuvastatin—coronary artery disease	0.000565	0.00325	CcSEcCtD
Tazarotene—Oedema—Clopidogrel—coronary artery disease	0.000564	0.00325	CcSEcCtD
Tazarotene—Erythema—Enalapril—coronary artery disease	0.000561	0.00323	CcSEcCtD
Tazarotene—Discomfort—Eplerenone—coronary artery disease	0.000554	0.00319	CcSEcCtD
Tazarotene—Erythema—Telmisartan—coronary artery disease	0.000554	0.00319	CcSEcCtD
Tazarotene—Photosensitivity reaction—Ramipril—coronary artery disease	0.000551	0.00317	CcSEcCtD
Tazarotene—Discomfort—Simvastatin—coronary artery disease	0.00054	0.00311	CcSEcCtD
Tazarotene—Pruritus—Gemfibrozil—coronary artery disease	0.000532	0.00306	CcSEcCtD
Tazarotene—Oedema—Simvastatin—coronary artery disease	0.000524	0.00302	CcSEcCtD
Tazarotene—Erythema—Perindopril—coronary artery disease	0.000523	0.00301	CcSEcCtD
Tazarotene—Pruritus—Ticagrelor—coronary artery disease	0.000519	0.00299	CcSEcCtD
Tazarotene—Erythema—Furosemide—coronary artery disease	0.000508	0.00293	CcSEcCtD
Tazarotene—Discomfort—Olmesartan—coronary artery disease	0.000507	0.00292	CcSEcCtD
Tazarotene—Photosensitivity reaction—Lisinopril—coronary artery disease	0.000499	0.00288	CcSEcCtD
Tazarotene—Oedema—Valsartan—coronary artery disease	0.000495	0.00285	CcSEcCtD
Tazarotene—Oedema—Olmesartan—coronary artery disease	0.000492	0.00283	CcSEcCtD
Tazarotene—Pain—Fenofibrate—coronary artery disease	0.000491	0.00282	CcSEcCtD
Tazarotene—Erythema—Losartan—coronary artery disease	0.00049	0.00282	CcSEcCtD
Tazarotene—Discomfort—Pravastatin—coronary artery disease	0.000488	0.00281	CcSEcCtD
Tazarotene—Pain—Clopidogrel—coronary artery disease	0.000482	0.00278	CcSEcCtD
Tazarotene—Oedema—Niacin—coronary artery disease	0.000481	0.00277	CcSEcCtD
Tazarotene—Pain—Lovastatin—coronary artery disease	0.000479	0.00276	CcSEcCtD
Tazarotene—Oedema peripheral—Ramipril—coronary artery disease	0.000476	0.00274	CcSEcCtD
Tazarotene—Discomfort—Trandolapril—coronary artery disease	0.000474	0.00273	CcSEcCtD
Tazarotene—Rash—Gemfibrozil—coronary artery disease	0.000474	0.00273	CcSEcCtD
Tazarotene—Oedema—Pravastatin—coronary artery disease	0.000474	0.00273	CcSEcCtD
Tazarotene—Dermatitis—Gemfibrozil—coronary artery disease	0.000473	0.00273	CcSEcCtD
Tazarotene—Discomfort—Enalapril—coronary artery disease	0.000472	0.00272	CcSEcCtD
Tazarotene—Pain—Ezetimibe—coronary artery disease	0.00047	0.0027	CcSEcCtD
Tazarotene—Pruritus—Rosuvastatin—coronary artery disease	0.000468	0.00269	CcSEcCtD
Tazarotene—Discomfort—Telmisartan—coronary artery disease	0.000466	0.00268	CcSEcCtD
Tazarotene—Oedema peripheral—Timolol—coronary artery disease	0.000465	0.00268	CcSEcCtD
Tazarotene—Rash—Ticagrelor—coronary artery disease	0.000463	0.00266	CcSEcCtD
Tazarotene—Dermatitis—Ticagrelor—coronary artery disease	0.000463	0.00266	CcSEcCtD
Tazarotene—Oedema—Trandolapril—coronary artery disease	0.00046	0.00265	CcSEcCtD
Tazarotene—Pain—Eplerenone—coronary artery disease	0.00046	0.00265	CcSEcCtD
Tazarotene—Oedema—Enalapril—coronary artery disease	0.000458	0.00264	CcSEcCtD
Tazarotene—Pruritus—Acetylsalicylic acid—coronary artery disease	0.000454	0.00261	CcSEcCtD
Tazarotene—Discomfort—Captopril—coronary artery disease	0.000453	0.00261	CcSEcCtD
Tazarotene—Oedema—Telmisartan—coronary artery disease	0.000452	0.0026	CcSEcCtD
Tazarotene—Pain—Simvastatin—coronary artery disease	0.000448	0.00258	CcSEcCtD
Tazarotene—Discomfort—Perindopril—coronary artery disease	0.00044	0.00253	CcSEcCtD
Tazarotene—Oedema peripheral—Lisinopril—coronary artery disease	0.000431	0.00248	CcSEcCtD
Tazarotene—Oedema—Perindopril—coronary artery disease	0.000427	0.00246	CcSEcCtD
Tazarotene—Pain—Olmesartan—coronary artery disease	0.000421	0.00242	CcSEcCtD
Tazarotene—Erythema—Ramipril—coronary artery disease	0.00042	0.00242	CcSEcCtD
Tazarotene—Rash—Rosuvastatin—coronary artery disease	0.000417	0.0024	CcSEcCtD
Tazarotene—Dermatitis—Rosuvastatin—coronary artery disease	0.000416	0.0024	CcSEcCtD
Tazarotene—Discomfort—Losartan—coronary artery disease	0.000412	0.00237	CcSEcCtD
Tazarotene—Pain—Niacin—coronary artery disease	0.000411	0.00237	CcSEcCtD
Tazarotene—Erythema—Timolol—coronary artery disease	0.000411	0.00237	CcSEcCtD
Tazarotene—Pruritus—Fenofibrate—coronary artery disease	0.000406	0.00234	CcSEcCtD
Tazarotene—Pain—Pravastatin—coronary artery disease	0.000405	0.00233	CcSEcCtD
Tazarotene—Rash—Acetylsalicylic acid—coronary artery disease	0.000405	0.00233	CcSEcCtD
Tazarotene—Dermatitis—Acetylsalicylic acid—coronary artery disease	0.000404	0.00233	CcSEcCtD
Tazarotene—Oedema—Losartan—coronary artery disease	0.0004	0.0023	CcSEcCtD
Tazarotene—Pruritus—Clopidogrel—coronary artery disease	0.000399	0.0023	CcSEcCtD
Tazarotene—Pruritus—Lovastatin—coronary artery disease	0.000396	0.00228	CcSEcCtD
Tazarotene—Pruritus—Ezetimibe—coronary artery disease	0.000389	0.00224	CcSEcCtD
Tazarotene—Pain—Telmisartan—coronary artery disease	0.000386	0.00222	CcSEcCtD
Tazarotene—Erythema—Lisinopril—coronary artery disease	0.000381	0.00219	CcSEcCtD
Tazarotene—Pruritus—Eplerenone—coronary artery disease	0.00038	0.00219	CcSEcCtD
Tazarotene—Pruritus—Simvastatin—coronary artery disease	0.000371	0.00213	CcSEcCtD
Tazarotene—Pain—Perindopril—coronary artery disease	0.000365	0.0021	CcSEcCtD
Tazarotene—Rash—Fenofibrate—coronary artery disease	0.000362	0.00208	CcSEcCtD
Tazarotene—Dermatitis—Fenofibrate—coronary artery disease	0.000361	0.00208	CcSEcCtD
Tazarotene—Rash—Clopidogrel—coronary artery disease	0.000356	0.00205	CcSEcCtD
Tazarotene—Dermatitis—Clopidogrel—coronary artery disease	0.000355	0.00204	CcSEcCtD
Tazarotene—Pain—Furosemide—coronary artery disease	0.000355	0.00204	CcSEcCtD
Tazarotene—Discomfort—Ramipril—coronary artery disease	0.000354	0.00204	CcSEcCtD
Tazarotene—Rash—Lovastatin—coronary artery disease	0.000353	0.00203	CcSEcCtD
Tazarotene—Dermatitis—Lovastatin—coronary artery disease	0.000353	0.00203	CcSEcCtD
Tazarotene—Pruritus—Valsartan—coronary artery disease	0.00035	0.00201	CcSEcCtD
Tazarotene—Pruritus—Olmesartan—coronary artery disease	0.000348	0.00201	CcSEcCtD
Tazarotene—Rash—Ezetimibe—coronary artery disease	0.000346	0.00199	CcSEcCtD
Tazarotene—Dermatitis—Ezetimibe—coronary artery disease	0.000346	0.00199	CcSEcCtD
Tazarotene—Discomfort—Timolol—coronary artery disease	0.000346	0.00199	CcSEcCtD
Tazarotene—Oedema—Ramipril—coronary artery disease	0.000343	0.00198	CcSEcCtD
Tazarotene—Pain—Losartan—coronary artery disease	0.000342	0.00197	CcSEcCtD
Tazarotene—Pruritus—Niacin—coronary artery disease	0.00034	0.00196	CcSEcCtD
Tazarotene—Rash—Eplerenone—coronary artery disease	0.000339	0.00195	CcSEcCtD
Tazarotene—Dermatitis—Eplerenone—coronary artery disease	0.000339	0.00195	CcSEcCtD
Tazarotene—Oedema—Timolol—coronary artery disease	0.000335	0.00193	CcSEcCtD
Tazarotene—Pruritus—Pravastatin—coronary artery disease	0.000335	0.00193	CcSEcCtD
Tazarotene—Rash—Simvastatin—coronary artery disease	0.00033	0.0019	CcSEcCtD
Tazarotene—Dermatitis—Simvastatin—coronary artery disease	0.00033	0.0019	CcSEcCtD
Tazarotene—Pruritus—Trandolapril—coronary artery disease	0.000325	0.00187	CcSEcCtD
Tazarotene—Pruritus—Enalapril—coronary artery disease	0.000324	0.00187	CcSEcCtD
Tazarotene—Discomfort—Lisinopril—coronary artery disease	0.000321	0.00185	CcSEcCtD
Tazarotene—Pruritus—Telmisartan—coronary artery disease	0.00032	0.00184	CcSEcCtD
Tazarotene—Rash—Valsartan—coronary artery disease	0.000312	0.0018	CcSEcCtD
Tazarotene—Dermatitis—Valsartan—coronary artery disease	0.000312	0.00179	CcSEcCtD
Tazarotene—Oedema—Lisinopril—coronary artery disease	0.000311	0.00179	CcSEcCtD
Tazarotene—Pruritus—Captopril—coronary artery disease	0.000311	0.00179	CcSEcCtD
Tazarotene—Rash—Olmesartan—coronary artery disease	0.00031	0.00179	CcSEcCtD
Tazarotene—Dermatitis—Olmesartan—coronary artery disease	0.00031	0.00179	CcSEcCtD
Tazarotene—Rash—Niacin—coronary artery disease	0.000303	0.00175	CcSEcCtD
Tazarotene—Dermatitis—Niacin—coronary artery disease	0.000303	0.00174	CcSEcCtD
Tazarotene—Pruritus—Perindopril—coronary artery disease	0.000302	0.00174	CcSEcCtD
Tazarotene—Rash—Pravastatin—coronary artery disease	0.000299	0.00172	CcSEcCtD
Tazarotene—Dermatitis—Pravastatin—coronary artery disease	0.000298	0.00172	CcSEcCtD
Tazarotene—Pruritus—Furosemide—coronary artery disease	0.000293	0.00169	CcSEcCtD
Tazarotene—Rash—Trandolapril—coronary artery disease	0.00029	0.00167	CcSEcCtD
Tazarotene—Dermatitis—Trandolapril—coronary artery disease	0.00029	0.00167	CcSEcCtD
Tazarotene—Rash—Enalapril—coronary artery disease	0.000289	0.00166	CcSEcCtD
Tazarotene—Dermatitis—Enalapril—coronary artery disease	0.000289	0.00166	CcSEcCtD
Tazarotene—Pain—Timolol—coronary artery disease	0.000287	0.00165	CcSEcCtD
Tazarotene—Rash—Telmisartan—coronary artery disease	0.000285	0.00164	CcSEcCtD
Tazarotene—Dermatitis—Telmisartan—coronary artery disease	0.000285	0.00164	CcSEcCtD
Tazarotene—Pruritus—Losartan—coronary artery disease	0.000283	0.00163	CcSEcCtD
Tazarotene—Rash—Captopril—coronary artery disease	0.000277	0.00159	CcSEcCtD
Tazarotene—Dermatitis—Captopril—coronary artery disease	0.000277	0.00159	CcSEcCtD
Tazarotene—Rash—Perindopril—coronary artery disease	0.000269	0.00155	CcSEcCtD
Tazarotene—Dermatitis—Perindopril—coronary artery disease	0.000269	0.00155	CcSEcCtD
Tazarotene—Pain—Lisinopril—coronary artery disease	0.000266	0.00153	CcSEcCtD
Tazarotene—Rash—Furosemide—coronary artery disease	0.000261	0.00151	CcSEcCtD
Tazarotene—Dermatitis—Furosemide—coronary artery disease	0.000261	0.0015	CcSEcCtD
Tazarotene—Rash—Losartan—coronary artery disease	0.000252	0.00145	CcSEcCtD
Tazarotene—Dermatitis—Losartan—coronary artery disease	0.000252	0.00145	CcSEcCtD
Tazarotene—Pruritus—Ramipril—coronary artery disease	0.000243	0.0014	CcSEcCtD
Tazarotene—Pruritus—Timolol—coronary artery disease	0.000237	0.00137	CcSEcCtD
Tazarotene—Pruritus—Lisinopril—coronary artery disease	0.00022	0.00127	CcSEcCtD
Tazarotene—Rash—Ramipril—coronary artery disease	0.000216	0.00125	CcSEcCtD
Tazarotene—Dermatitis—Ramipril—coronary artery disease	0.000216	0.00124	CcSEcCtD
Tazarotene—Rash—Timolol—coronary artery disease	0.000211	0.00122	CcSEcCtD
Tazarotene—Dermatitis—Timolol—coronary artery disease	0.000211	0.00122	CcSEcCtD
Tazarotene—Rash—Lisinopril—coronary artery disease	0.000196	0.00113	CcSEcCtD
Tazarotene—Dermatitis—Lisinopril—coronary artery disease	0.000196	0.00113	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—coronary artery disease	8.69e-05	0.000407	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—ESR1—coronary artery disease	8.51e-05	0.000398	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—NPPA—coronary artery disease	8.45e-05	0.000395	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PPAP2B—coronary artery disease	8.35e-05	0.000391	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—coronary artery disease	8.33e-05	0.00039	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—GPX3—coronary artery disease	8.28e-05	0.000387	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—NPPA—coronary artery disease	8.1e-05	0.000379	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—NPPA—coronary artery disease	8.1e-05	0.000379	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—ALDH2—coronary artery disease	8.05e-05	0.000377	CbGpPWpGaD
Tazarotene—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—coronary artery disease	8.01e-05	0.000375	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—TGFB1—coronary artery disease	7.98e-05	0.000373	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—CYP2C19—coronary artery disease	7.84e-05	0.000367	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—IL6—coronary artery disease	7.84e-05	0.000367	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—MAPK1—coronary artery disease	7.82e-05	0.000366	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—PPARG—coronary artery disease	7.77e-05	0.000363	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—CYP2C19—coronary artery disease	7.74e-05	0.000362	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—GSTT1—coronary artery disease	7.66e-05	0.000358	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—TGFB1—coronary artery disease	7.65e-05	0.000358	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—ESR1—coronary artery disease	7.64e-05	0.000357	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—GCLC—coronary artery disease	7.57e-05	0.000354	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—PSMA6—coronary artery disease	7.56e-05	0.000354	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—PSMB5—coronary artery disease	7.56e-05	0.000354	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—MAPK1—coronary artery disease	7.5e-05	0.000351	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—TNF—coronary artery disease	7.45e-05	0.000348	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—CTGF—coronary artery disease	7.39e-05	0.000346	CbGpPWpGaD
Tazarotene—CYP2C8—Arachidonic acid metabolism—PTGS2—coronary artery disease	7.39e-05	0.000346	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—ESR1—coronary artery disease	7.32e-05	0.000342	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—ESR1—coronary artery disease	7.32e-05	0.000342	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—TNF—coronary artery disease	7.14e-05	0.000334	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—SERPINE1—coronary artery disease	7e-05	0.000327	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—PPARG—coronary artery disease	6.97e-05	0.000326	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—HMGCS2—coronary artery disease	6.92e-05	0.000324	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—GK—coronary artery disease	6.92e-05	0.000324	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—PIK3CA—coronary artery disease	6.79e-05	0.000318	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—PSMA6—coronary artery disease	6.78e-05	0.000317	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—PSMB5—coronary artery disease	6.78e-05	0.000317	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—ESR2—coronary artery disease	6.76e-05	0.000316	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—JUNB—coronary artery disease	6.76e-05	0.000316	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—HSPA1A—coronary artery disease	6.76e-05	0.000316	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—PPARG—coronary artery disease	6.68e-05	0.000312	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—PPARG—coronary artery disease	6.68e-05	0.000312	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—CTGF—coronary artery disease	6.63e-05	0.00031	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—PIK3CA—coronary artery disease	6.51e-05	0.000304	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—PSMB5—coronary artery disease	6.5e-05	0.000304	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—PSMB5—coronary artery disease	6.5e-05	0.000304	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—PSMA6—coronary artery disease	6.5e-05	0.000304	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—PSMA6—coronary artery disease	6.5e-05	0.000304	CbGpPWpGaD
Tazarotene—CYP2C8—Phase 1 - Functionalization of compounds—POMC—coronary artery disease	6.49e-05	0.000304	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—CTGF—coronary artery disease	6.35e-05	0.000297	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—CTGF—coronary artery disease	6.35e-05	0.000297	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—UGCG—coronary artery disease	6.33e-05	0.000296	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—SERPINE1—coronary artery disease	6.28e-05	0.000294	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—JUNB—coronary artery disease	6.06e-05	0.000284	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—HSPA1A—coronary artery disease	6.06e-05	0.000284	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—ESR2—coronary artery disease	6.06e-05	0.000284	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—SERPINE1—coronary artery disease	6.02e-05	0.000282	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—SERPINE1—coronary artery disease	6.02e-05	0.000282	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—GGT1—coronary artery disease	5.91e-05	0.000276	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—JUNB—coronary artery disease	5.81e-05	0.000272	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—JUNB—coronary artery disease	5.81e-05	0.000272	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—HSPA1A—coronary artery disease	5.81e-05	0.000272	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—ESR2—coronary artery disease	5.81e-05	0.000272	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—ESR2—coronary artery disease	5.81e-05	0.000272	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—HSPA1A—coronary artery disease	5.81e-05	0.000272	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—AKT1—coronary artery disease	5.54e-05	0.000259	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PLIN1—coronary artery disease	5.53e-05	0.000259	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—SIRT1—coronary artery disease	5.44e-05	0.000255	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CA5B—coronary artery disease	5.37e-05	0.000251	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—AKT1—coronary artery disease	5.32e-05	0.000249	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—GSTP1—coronary artery disease	5.31e-05	0.000248	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—GSTP1—coronary artery disease	5.23e-05	0.000245	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—AKR1B1—coronary artery disease	5e-05	0.000234	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—SIRT1—coronary artery disease	4.88e-05	0.000228	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—GSTM1—coronary artery disease	4.88e-05	0.000228	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—GSTM1—coronary artery disease	4.81e-05	0.000225	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—PPP2CA—coronary artery disease	4.81e-05	0.000225	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—SLC27A1—coronary artery disease	4.8e-05	0.000224	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—PRKCD—coronary artery disease	4.72e-05	0.000221	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—CPT1B—coronary artery disease	4.7e-05	0.00022	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—LCAT—coronary artery disease	4.7e-05	0.00022	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—SIRT1—coronary artery disease	4.68e-05	0.000219	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—SIRT1—coronary artery disease	4.68e-05	0.000219	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—APOA4—coronary artery disease	4.62e-05	0.000216	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CKMT1B—coronary artery disease	4.56e-05	0.000213	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—TXNRD1—coronary artery disease	4.32e-05	0.000202	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—CYP11B2—coronary artery disease	4.32e-05	0.000202	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—PPP2CA—coronary artery disease	4.31e-05	0.000202	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—PRKCD—coronary artery disease	4.23e-05	0.000198	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—ARNTL—coronary artery disease	4.19e-05	0.000196	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—HADH—coronary artery disease	4.19e-05	0.000196	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—MAPK14—coronary artery disease	4.18e-05	0.000195	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—PPP2CA—coronary artery disease	4.13e-05	0.000193	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—PPP2CA—coronary artery disease	4.13e-05	0.000193	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—ESR1—coronary artery disease	4.1e-05	0.000192	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—PRKCD—coronary artery disease	4.06e-05	0.00019	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—PRKCD—coronary artery disease	4.06e-05	0.00019	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—GPX2—coronary artery disease	3.97e-05	0.000186	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—APOA2—coronary artery disease	3.97e-05	0.000186	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G2A—coronary artery disease	3.97e-05	0.000186	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—ABCG5—coronary artery disease	3.93e-05	0.000184	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—GPX4—coronary artery disease	3.93e-05	0.000184	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—HADHA—coronary artery disease	3.88e-05	0.000182	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—LPA—coronary artery disease	3.79e-05	0.000177	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—MAPK14—coronary artery disease	3.75e-05	0.000175	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—PPARG—coronary artery disease	3.74e-05	0.000175	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CKM—coronary artery disease	3.72e-05	0.000174	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—UQCRFS1—coronary artery disease	3.72e-05	0.000174	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PPAP2B—coronary artery disease	3.72e-05	0.000174	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—ESR1—coronary artery disease	3.68e-05	0.000172	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—APOA5—coronary artery disease	3.64e-05	0.00017	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—MAPK14—coronary artery disease	3.59e-05	0.000168	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—MAPK14—coronary artery disease	3.59e-05	0.000168	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—P4HB—coronary artery disease	3.57e-05	0.000167	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—ESR1—coronary artery disease	3.52e-05	0.000165	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—ESR1—coronary artery disease	3.52e-05	0.000165	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G1B—coronary artery disease	3.5e-05	0.000164	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PYGM—coronary artery disease	3.46e-05	0.000162	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—SULT4A1—coronary artery disease	3.46e-05	0.000162	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ALDH6A1—coronary artery disease	3.46e-05	0.000162	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PDK4—coronary artery disease	3.46e-05	0.000162	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CKMT2—coronary artery disease	3.46e-05	0.000162	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—POMC—coronary artery disease	3.45e-05	0.000161	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—SERPINE1—coronary artery disease	3.37e-05	0.000158	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—PPARG—coronary artery disease	3.35e-05	0.000157	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—PPARG—coronary artery disease	3.22e-05	0.00015	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—PPARG—coronary artery disease	3.22e-05	0.00015	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PFKM—coronary artery disease	3.08e-05	0.000144	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—HMGCS2—coronary artery disease	3.08e-05	0.000144	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GK—coronary artery disease	3.08e-05	0.000144	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GATM—coronary artery disease	3.08e-05	0.000144	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GYG1—coronary artery disease	3.08e-05	0.000144	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—LDHA—coronary artery disease	3.08e-05	0.000144	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—SERPINE1—coronary artery disease	3.02e-05	0.000141	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—LIPC—coronary artery disease	3.01e-05	0.000141	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C19—coronary artery disease	3.01e-05	0.000141	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3C2A—coronary artery disease	3.01e-05	0.000141	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—APOC3—coronary artery disease	2.99e-05	0.00014	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—LDLR—coronary artery disease	2.98e-05	0.000139	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GCH1—coronary artery disease	2.94e-05	0.000138	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—AK1—coronary artery disease	2.94e-05	0.000138	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—CETP—coronary artery disease	2.91e-05	0.000136	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—SERPINE1—coronary artery disease	2.9e-05	0.000136	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—SERPINE1—coronary artery disease	2.9e-05	0.000136	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—SDC1—coronary artery disease	2.87e-05	0.000134	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PLCD1—coronary artery disease	2.82e-05	0.000132	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—UGCG—coronary artery disease	2.82e-05	0.000132	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PPAT—coronary artery disease	2.82e-05	0.000132	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—MDH2—coronary artery disease	2.82e-05	0.000132	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PGM1—coronary artery disease	2.71e-05	0.000127	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—coronary artery disease	2.65e-05	0.000124	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—HMGCR—coronary artery disease	2.63e-05	0.000123	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CKB—coronary artery disease	2.62e-05	0.000123	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PYGB—coronary artery disease	2.62e-05	0.000123	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—DLAT—coronary artery disease	2.46e-05	0.000115	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PFKFB3—coronary artery disease	2.46e-05	0.000115	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—COX5B—coronary artery disease	2.46e-05	0.000115	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GSTM2—coronary artery disease	2.46e-05	0.000115	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PLIN1—coronary artery disease	2.46e-05	0.000115	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—coronary artery disease	2.34e-05	0.00011	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—SULT1E1—coronary artery disease	2.34e-05	0.000109	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—coronary artery disease	2.27e-05	0.000106	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—HK2—coronary artery disease	2.23e-05	0.000104	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—AKR1B1—coronary artery disease	2.23e-05	0.000104	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—SLC27A1—coronary artery disease	2.14e-05	0.0001	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—LCAT—coronary artery disease	2.1e-05	9.8e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CPT1B—coronary artery disease	2.1e-05	9.8e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—APOA4—coronary artery disease	2.06e-05	9.62e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PPARGC1A—coronary artery disease	2.02e-05	9.45e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PDHA1—coronary artery disease	1.99e-05	9.29e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GCLM—coronary artery disease	1.99e-05	9.29e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—APOB—coronary artery disease	1.93e-05	9.01e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—TXNRD1—coronary artery disease	1.92e-05	9e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CYP11B2—coronary artery disease	1.92e-05	9e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—SLC22A3—coronary artery disease	1.89e-05	8.86e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ARNTL—coronary artery disease	1.87e-05	8.74e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—HADH—coronary artery disease	1.87e-05	8.74e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	1.84e-05	8.6e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	1.79e-05	8.39e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—APOA2—coronary artery disease	1.77e-05	8.28e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PLA2G2A—coronary artery disease	1.77e-05	8.28e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GPX2—coronary artery disease	1.77e-05	8.28e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—HK1—coronary artery disease	1.75e-05	8.18e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ABCG5—coronary artery disease	1.75e-05	8.18e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—SULT1A1—coronary artery disease	1.75e-05	8.18e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GPX4—coronary artery disease	1.75e-05	8.18e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	1.75e-05	8.17e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—HADHA—coronary artery disease	1.73e-05	8.08e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GSTA1—coronary artery disease	1.71e-05	7.99e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—LPA—coronary artery disease	1.69e-05	7.9e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PLCB3—coronary artery disease	1.64e-05	7.65e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—APOA5—coronary artery disease	1.62e-05	7.58e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—P4HB—coronary artery disease	1.59e-05	7.43e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	1.57e-05	7.36e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PLA2G1B—coronary artery disease	1.56e-05	7.29e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	1.54e-05	7.21e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	1.52e-05	7.13e-05	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—AKT1—coronary artery disease	1.48e-05	6.92e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—VCAN—coronary artery disease	1.47e-05	6.87e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ALDOA—coronary artery disease	1.46e-05	6.82e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—DCN—coronary artery disease	1.42e-05	6.62e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ALDH2—coronary artery disease	1.38e-05	6.44e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	1.34e-05	6.28e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CYP2C19—coronary artery disease	1.34e-05	6.28e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—HBA1—coronary artery disease	1.34e-05	6.28e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—LIPC—coronary artery disease	1.34e-05	6.28e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PIK3C2A—coronary artery disease	1.34e-05	6.28e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—APOC3—coronary artery disease	1.33e-05	6.24e-05	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—AKT1—coronary artery disease	1.33e-05	6.2e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—LDLR—coronary artery disease	1.33e-05	6.2e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	1.32e-05	6.19e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GSTT1—coronary artery disease	1.31e-05	6.13e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—SLC9A1—coronary artery disease	1.31e-05	6.13e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CETP—coronary artery disease	1.29e-05	6.06e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GCLC—coronary artery disease	1.29e-05	6.06e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—SDC1—coronary artery disease	1.28e-05	5.99e-05	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—AKT1—coronary artery disease	1.27e-05	5.95e-05	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—AKT1—coronary artery disease	1.27e-05	5.95e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PSMA6—coronary artery disease	1.21e-05	5.66e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PSMB5—coronary artery disease	1.21e-05	5.66e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	1.21e-05	5.65e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CTGF—coronary artery disease	1.18e-05	5.53e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—HMGCR—coronary artery disease	1.17e-05	5.48e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GOT2—coronary artery disease	1.17e-05	5.48e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PLCB1—coronary artery disease	1.08e-05	5.04e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	1.06e-05	4.94e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ABCA1—coronary artery disease	1.04e-05	4.88e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GGT1—coronary artery disease	1.01e-05	4.73e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GOT1—coronary artery disease	1.01e-05	4.73e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GSTP1—coronary artery disease	9.08e-06	4.25e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PPARGC1A—coronary artery disease	8.99e-06	4.21e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—HMOX1—coronary artery disease	8.95e-06	4.19e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CAT—coronary artery disease	8.83e-06	4.13e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—APOB—coronary artery disease	8.57e-06	4.01e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GSTM1—coronary artery disease	8.34e-06	3.9e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—LPL—coronary artery disease	8.19e-06	3.83e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GPX1—coronary artery disease	7.99e-06	3.74e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CD36—coronary artery disease	7.78e-06	3.64e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PPP2CA—coronary artery disease	7.68e-06	3.59e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—MTHFR—coronary artery disease	7.37e-06	3.45e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—AGT—coronary artery disease	7e-06	3.28e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—APOE—coronary artery disease	6.86e-06	3.21e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—APOA1—coronary artery disease	6.78e-06	3.17e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	6.5e-06	3.04e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PPARG—coronary artery disease	5.98e-06	2.8e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—POMC—coronary artery disease	5.9e-06	2.76e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ALB—coronary artery disease	5.37e-06	2.51e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—NOS3—coronary artery disease	5.14e-06	2.41e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PTGS2—coronary artery disease	4.7e-06	2.2e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PIK3CA—coronary artery disease	2.89e-06	1.35e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—AKT1—coronary artery disease	2.36e-06	1.11e-05	CbGpPWpGaD
